Live Breaking News & Updates on Paulb Manning|Page 4
Stay updated with breaking news from Paulb manning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective lowered by Canaccord Genuity Group from $13.00 to $7.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts also recently commented on the stock. […] ....
Needham & Company LLC reiterated their buy rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other research firms also recently commented on VRCA. Royal Bank of Canada raised their target price […] ....
Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They currently have a $10.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 91.94% from […] ....
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price objective hoisted by HC Wainwright from $11.00 to $12.00 in a report issued on Thursday morning, Marketbeat.com reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Verrica Pharmaceuticals’ FY2026 earnings at $0.45 EPS. Several other equities research analysts […] ....
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) Director Paul B. Manning bought 200,000 shares of Verrica Pharmaceuticals stock in a transaction on Monday, July 24th. The stock was acquired at an average cost of $5.02 per share, for a total transaction of $1,004,000.00. Following the acquisition, the director now owns 7,851,128 shares in the […] ....